AVE 16.7% 0.3¢ avecho biotechnology limited

financial misappropriation ann is out, page-69

  1. 5,322 Posts.
    Turps OK- here is what I see- As POH CEO, (and before 2010 as Executive Vice President of Research & Development) , Esra was uniquely positioned to call for tenders or quotes, award the business to her preferred crooked supplier(s), approve same suppliers fake or inflated invoices and signoff on the payment. Unless somebody in accounts or senior management had a suspicion that POH was paying too much for a raw material the fraud could and did go undetected. Keeping in mind that Esra would be ordering lab equipment; rare and expensive raw materials - stuff like radioactive isotopes from Eastern Europe, for which there is no set market price- her deception was easy to hide in plain sight. Simples.

    POHs new CFO however must have gone deeper ( she must be powered by TPM) than any CFO before her. Perhaps Esra got careless- whatever gave her up- thankgod she and her gang of thieves have been caught before they emptied the bank
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(16.7%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $3.461K 1.175M

Buyers (Bids)

No. Vol. Price($)
65 101062608 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 20323507 8
View Market Depth
Last trade - 15.44pm 16/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.